Cyanvac LLC’s mission is to tackle the world’s most pressing infectious diseases with vaccines that can be easily delivered worldwide.
Cyanvac LLC is developing vaccines using a proprietary transformational parainfluenza virus 5 (PIV5)-based vector. Our platform enables us to make robust, intranasal vaccines that are easy to administer, easy to transport, and easy to manufacture.
